We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

[NAIROBI] Researchers and policymakers met in Kenya this week to discuss ways that biotechnology could contribute to the continent's development.

The meeting held on 25-28 July was the 4th gathering of the High-Level Panel on Biotechnology, set up by the African Union and the New Partnership for Africa's Development to provide policy advice to African leaders.

The panel discussed a draft report, which it plans to refine and submit to the annual summit of African heads of state in January 2007. It has requested comments on the report from researchers, policymakers and the general public.

The report identifies ways of building the continent's capacity to use biotechnology to improve health, agriculture and industry, and urges African countries and regions to collaborate on biotechnology research.

The panel's co-chair, Calestous Juma of Harvard University, United States, said that people who say biotechnology is being forced on Africa have a limited view of what it is taking place and are only considering genetically modified (GM) organisms.

He pointed out that serious research in various aspects of biotechnology was already underway in African countries including Egypt, Kenya and South Africa.

Panel member Tewolde Egziabher, the director-general of Ethiopia's Environmental Protection Authority, said that biosafety issues relating to genetic modification are a small but vital component of biotechnology as a whole.

He said some industrialised countries are trying to force GM products onto African countries that have no regulatory frameworks or laws in place to mitigate adverse effects that these products could generate.

He said such countries are undermining the Cartagena Protocol, an international instrument intended to protect biodiversity from potential harm posed by GM organisms (see The Cartagena Protocol: the debate goes on).

Juma, however, is less worried about biosafety. "As far as I am concerned GM products are as safe as conventional ones, and both have risks," he said.

Link to draft report on biotechnology and African development[509KB]

The draft report is available for public comment. Comments should be submitted by 31 August 2006 to [email protected]

SciDev.Net also welcomes views on the report and will consider publishing those sent to [email protected]